Literature DB >> 10423339

Comparison of the caldesmon content of cardiac and smooth muscle.

S V Phillips1, G C Scott-Woo, M P Walsh, G J Kargacin.   

Abstract

The high abundance of caldesmon in smooth muscle and its ability to inhibit actomyosin ATPase activity have led to the hypothesis that caldesmon modulates contractile activity. It has also been proposed, however, that caldesmon acts as a structural protein in muscle and non-muscle cells. We have determined the caldesmon content of mammalian cardiac muscle and have found that caldesmon is 200-fold less abundant in cardiac muscle than it is in gizzard smooth muscle. This finding argues against a role for caldesmon in the modulation of cardiac contractility. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423339     DOI: 10.1006/jmcc.1999.0980

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  2 in total

1.  Inhibition of SERCA2 Ca(2+)-ATPases by Cs(+).

Authors:  Gary J Kargacin; Roozbeh Aschar-Sobbi; Margaret E Kargacin
Journal:  Pflugers Arch       Date:  2004-10-12       Impact factor: 3.657

2.  Postnatal changes in caldesmon expression and localization in cardiac myocytes.

Authors:  Gail A McMartin; Erwin Wirch; Natalia Abraham; Gary J Kargacin
Journal:  J Anat       Date:  2003-10       Impact factor: 2.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.